Ramsay Health Care (ASX:RHC) Cash Conversion Cycle: -71.92 (As of Dec. 2025)


ASX:RHC Ramsay Health Care Ltd ASX:RHC
87 GF Score
Price A$43.10
GF Value A$50.75
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Ramsay Health Care Cash Conversion Cycle?

Ramsay Health Care ASX:RHC +0.84% 87 Cash Conversion Cycle is -71.92 as of Dec. 2025. GuruFocus rates ASX:RHC with a GF Score™ of 87/100 and a GF Value™ of A$50.75 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Ramsay Health Care's Days Sales Outstanding for the six months ended in Dec. 2025 was 52.05.
Ramsay Health Care's Days Inventory for the six months ended in Dec. 2025 was 35.3.
Ramsay Health Care's Days Payable for the six months ended in Dec. 2025 was 159.27.
Therefore, Ramsay Health Care's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2025 was -71.92.


Ramsay Health Care  (ASX:RHC) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Ramsay Health Care Cash Conversion Cycle Related Terms


Ramsay Health Care Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Ramsay Health Care's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Health Care Cash Conversion Cycle Chart

Ramsay Health Care Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.77 -49.39 -60.72 -60.52 -62.83

Ramsay Health Care Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -130.41 -130.24 -126.63 -120.66 -71.92

ASX:RHC vs HCA, THC, DVA: Cash Conversion Cycle Comparison

For the Medical Care Facilities subindustry, Ramsay Health Care's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ramsay Health Care Cash Conversion Cycle vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Ramsay Health Care's Cash Conversion Cycle falls into.


ASX:RHC
87GF Score
Ramsay Health Care Ltd ASX:RHC
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Health Care Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Ramsay Health Care's Cash Conversion Cycle for the fiscal year that ended in Jun. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=55.48+35.72-154.03
=-62.83

Ramsay Health Care's Cash Conversion Cycle for the quarter that ended in Dec. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=52.05+35.3-159.27
=-71.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of -71.92 mean?
Ramsay Health Care (ASX:RHC) has a Cash Conversion Cycle of -71.92 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Ramsay Health Care and its competitors.
Is Ramsay Health Care's Cash Conversion Cycle too high?
Ramsay Health Care's current Cash Conversion Cycle is -71.92. Overall, Ramsay Health Care has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Cash Conversion Cycle compare to HCA and THC?
Ramsay Health Care's Cash Conversion Cycle of -71.92 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Conversion Cycle is 18.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Healthcare Providers & Services company?
The median Cash Conversion Cycle among Healthcare Providers & Services companies is 18.32, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Ramsay Health Care and its competitors. For the Healthcare Providers & Services industry, the median Cash Conversion Cycle is 18.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current Cash Conversion Cycle is -71.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.75, compared to a current price of A$43.10 — trading 15.1% below its estimated fair value. The current Cash Conversion Cycle is -71.92. Ramsay Health Care's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Cash Conversion Cycle is -71.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued. The current stock price of A$43.10 is trading 15.1% below its estimated GF Value™ of A$50.75. GuruFocus considers Ramsay Health Care to be Modestly Undervalued.

Key valuation signals for ASX:RHC:

  • Cash Conversion Cycle: -71.92
  • GF Value™: A$50.75 vs. price of A$43.10 (15.1% below fair value)
  • GF Score™: 87/100 with 9 warning signs

No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ramsay Health Care Business Description

Address 126 Phillip Street, Suite 18.03, Level 18, Deutsche Bank Place, Sydney, NSW, AUS, 2000
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
87GF Score

Get the complete analysis for ASX:RHC

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$43.10
Price
A$50.75
GF Value